DISTÚRBIOS HEMORRÁGICOS BIBLIOGRAFIA
¤ Abramson N.; Abramson, S. Hypercoagulability: Clinical Assessment and treatment. [South Med J 94(10):997-1001,2001 Southern Medical Association] [texto integral]
¤ Aledort LM, Green D, and Teitel JM. Unexpected Bleeding Disorders. The American Society of Hematology. Hematology 2001:306-321 [texto integral]
¤ Bernard GR. The Pathophysiology and Treatment of Sepsis: A Review of Current Information. Medscape, CME, Release Date: October 25, 2000.
[texto integral]
¤ Biron C, Mahieu B, Rochette A, et al. Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. J Lab Clin Med. 1999;134:605-9.
¤ Bone RC, Grodzin CJ and Balk RA. Sepsis: A New Hypothesis for Pathogenesis of the Disease Process. Chest. 1997;112:235-43.
[texto integral-PDF]
¤ Bonnefoy A, Liu Q, et al. Efficiency of Platelet Adhesion to Fibrinogen Depends on both Cell Activation and Flow. Biophys J, June 2000 78(6)2834-2843.
[texto integral]
¤ Carvalho AC, Freeman NJ. How Coagulation Defects Alter Outcome in Sepsis. Survival May Depend on Reversing Procoagulant Conditions. J Crit Illness. 1994;9:51-75.
¤ Cattaneo M, Fedrici AB, Lecchi A, et al. Evaluation of the PFA-100 System in the diagnosis and therapeutic minitoring of patientes with von Willebrand disease. Thromb Haemost. 1999;82:35-9.
¤ Cines DB, Pollak ES, Buck CA, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders. Blood. 1998;91:3527-3561.
[texto integral]
¤ Esmon NL and Esmon CT. Protein C and the Endothelium. Semin Thromb Hemost. 1988;14:210-15.
¤ Famadas LC. Emergências nas Doenças Hemorrágicas. Editora Centro de Hematologia Santa Catarina. Rio de Janeiro, 1979.
¤ Federici AB, Stabile F, Castaman G, et al. Treatment of Acquired von Willebran Syndrome in Patients With Monoclonal Gammopathy of Uncertain Significance: Comparison of Three Different Therapeutic Approaches. Blood. 1998; 92(8):
2707-11.
[texto integral]
¤ Fressinaud E, Veyradier A, Sigaud M, et al. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyzer at high shear rates. Br J Haematol. 1999;106:777-83.
¤ Furlong MA. Disseminated Intravascular Coagulation. eMedicine Journal, September 11 2001, Volume 2, Number 9.
[texto integral]
¤ Galardy PJ. Consumption Coagulopathy. eMedicine Journal, February 1 2002, Volume 3, Number 2.
[texto integral]
¤ Gando S, Nanzaki S, Sasaki S, et al. Activation of the Extrinsic Coagulation Pathway in Patients with Severe Sepsis and Septic Shock. Crit Care Med. 1988;26:2005-9.
¤ Geil JD. Von Willebrand Disease. eMedicine Journal. February 5 2002;3(2) [texto integral]
¤ Gordon BR. Medical writer: Robert McCarth, PhD. The Pathophysiology and Treatment of Sepsis: A Review of Current Information. Medscape, 2001.
[texto integral]
¤ Goris JA, Boekhorst TPA, Nuytinck JKS, et al. Multiple Organ Failure: Generalized Autodestructive Inflammation? Arch Surg. 1985;120:1109-15.
¤ Handin RI in Harrison's Principles of Internal Medicine. Part two - Section 10 - Hematologic Alterations. 60. Bleedings and thrombosis. Teton Viewer: Harrison's 14 th Edition, 2000. McGraw-Hill. CD-ROM.
¤ Hursting MJ,a, Zehnder JL and James L. Joffrion JL. The International Normalized Ratio during Concurrent Warfarin and Argatroban Anticoagulation: Differential Contributions of Each Agent and Effects of the Choice of Thromboplastin Used. Clinical Chemistry. 1999;45:409-412.
[texto integral]
¤ Levi M. Disseminated Intravascular Coagulation: New Diagnostic Criteria and Supportive Treatmente Strategies. 47 th Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis. July 6-7, 2001, Paris, France. Medscape Cardiology, 2001.
¤ Levi M, ten Cate H, van der Poll T, et al. Pathogenesis of Disseminated Intravascular Coagulation in Sepsis. JMA. 1993;270:975-9.
¤ Lopes JA, Andrews RK, Afshar-Kharghan V, et al. Bernard-Soulier Syndrome. Blood 1998;91(12): 4397-4418.
[texto integral]
¤ Mannucci PM, Lombardi R, Bader R, et al. Studies on the Pathophysiology of Acquired von Willebrand Disease in Seven patients with Lymphoproliferative Disorders or Benign Monoclonal Gammopathies. Blood 1984;64:614.
¤ Mannucci PM and Remuzzi G. von Willebrand Factor Cleaving Protease in Patients with and without Thrombotic Microangiopathies (TTP and HUS) in Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders. Hematology 2001:282-305.
[texto integral]
¤ Mohri H, Motomura S, Kanamori H, et al. Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome. Blood. 1998; 91(10):3623-29.
[texto integral]
¤ Martin GS. The Complex Role of Coagulation in the Pathophysiology of Sepsis. 30 th International Educational and Scientific Symposium of the Society of Critical Care Medicine. Day 1 - February 10, 2001
¤ Martin GS. Current Management Strategies for Severe Sepsis and Septic Shock. 67 th Annual Sceintific Assembly of the American College of Chest Physicians. November 4 - 8, 2001, Philadelphia, Pennsylvania.
[texto integral]
¤ Martin GS. Sepsis: An Evolution of Concepts and Definitions. 31 th International Educational and Scientific Symposium of the Society of Critical Care Medicine. January 26 - 30, 2002, San Diego, California. [texto integral]
¤ Mutunga M, Fulton B, Bullock R, et al. Circulating Endothelial Cells in Patients with Septic Shock. Am J Respir Crit Care Med. January 2001;163:195-200.
[texto integral]
¤ Poller L. Progress in standardization in anticoagulant control. Hematol Rev Commun 1987;1:225-41.
¤ Rao AK and Gabbeta J. Congenital Disorders of Platelet Signal Transduction. Arterioscler Thromb Vasc Biol. 2000;20:285-9.
[texto integral]
¤ Salgado DR. Sepse e choque séptico: fisiopatogenia. Artigo do site Medstudents. [texto integral]
¤ Schmaier AH. Disseminated Intravascular Coagulation. eMedicine Journal, November 23 2001, Volume 2, Number 11.
[texto integral]
¤ Sharma S. Septic Shock. eMedicine Journal, April 8 2002, Volume 3, Number 4.
[texto integral]
¤ Triplett DA. Coagulation and Bleeding Disorders: Reviw and Update. Clinical Chemistry 2000; 46(8):1260-69.
[texto integral]
¤ White GC. von Willebran's Disease. Education Program. IX th Congress of the International Society of Haematology. Asian-Pacific Division. Bangkok, Thailand. Oct. 24-28,1999.
[texto integral]
¤ Zhou Q, Sims PJ and Wiedmer T. Expression of Proteins Controlling Transbilayer Movement of Plasma Membrane Phospholipids in the B Lymphocytes From a Patient With Scott Syndrome. Blood. 1998;92(5):1707-12.
[texto integral]
¤ Aledort LM, Green D, and Teitel JM. Unexpected Bleeding Disorders. The American Society of Hematology. Hematology 2001:306-321 [texto integral]
¤ Bernard GR. The Pathophysiology and Treatment of Sepsis: A Review of Current Information. Medscape, CME, Release Date: October 25, 2000.
[texto integral]
¤ Biron C, Mahieu B, Rochette A, et al. Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. J Lab Clin Med. 1999;134:605-9.
¤ Bone RC, Grodzin CJ and Balk RA. Sepsis: A New Hypothesis for Pathogenesis of the Disease Process. Chest. 1997;112:235-43.
[texto integral-PDF]
¤ Bonnefoy A, Liu Q, et al. Efficiency of Platelet Adhesion to Fibrinogen Depends on both Cell Activation and Flow. Biophys J, June 2000 78(6)2834-2843.
[texto integral]
¤ Carvalho AC, Freeman NJ. How Coagulation Defects Alter Outcome in Sepsis. Survival May Depend on Reversing Procoagulant Conditions. J Crit Illness. 1994;9:51-75.
¤ Cattaneo M, Fedrici AB, Lecchi A, et al. Evaluation of the PFA-100 System in the diagnosis and therapeutic minitoring of patientes with von Willebrand disease. Thromb Haemost. 1999;82:35-9.
¤ Cines DB, Pollak ES, Buck CA, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders. Blood. 1998;91:3527-3561.
[texto integral]
¤ Esmon NL and Esmon CT. Protein C and the Endothelium. Semin Thromb Hemost. 1988;14:210-15.
¤ Famadas LC. Emergências nas Doenças Hemorrágicas. Editora Centro de Hematologia Santa Catarina. Rio de Janeiro, 1979.
¤ Federici AB, Stabile F, Castaman G, et al. Treatment of Acquired von Willebran Syndrome in Patients With Monoclonal Gammopathy of Uncertain Significance: Comparison of Three Different Therapeutic Approaches. Blood. 1998; 92(8):
2707-11.
[texto integral]
¤ Fressinaud E, Veyradier A, Sigaud M, et al. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyzer at high shear rates. Br J Haematol. 1999;106:777-83.
¤ Furlong MA. Disseminated Intravascular Coagulation. eMedicine Journal, September 11 2001, Volume 2, Number 9.
[texto integral]
¤ Galardy PJ. Consumption Coagulopathy. eMedicine Journal, February 1 2002, Volume 3, Number 2.
[texto integral]
¤ Gando S, Nanzaki S, Sasaki S, et al. Activation of the Extrinsic Coagulation Pathway in Patients with Severe Sepsis and Septic Shock. Crit Care Med. 1988;26:2005-9.
¤ Geil JD. Von Willebrand Disease. eMedicine Journal. February 5 2002;3(2) [texto integral]
¤ Gordon BR. Medical writer: Robert McCarth, PhD. The Pathophysiology and Treatment of Sepsis: A Review of Current Information. Medscape, 2001.
[texto integral]
¤ Goris JA, Boekhorst TPA, Nuytinck JKS, et al. Multiple Organ Failure: Generalized Autodestructive Inflammation? Arch Surg. 1985;120:1109-15.
¤ Handin RI in Harrison's Principles of Internal Medicine. Part two - Section 10 - Hematologic Alterations. 60. Bleedings and thrombosis. Teton Viewer: Harrison's 14 th Edition, 2000. McGraw-Hill. CD-ROM.
¤ Hursting MJ,a, Zehnder JL and James L. Joffrion JL. The International Normalized Ratio during Concurrent Warfarin and Argatroban Anticoagulation: Differential Contributions of Each Agent and Effects of the Choice of Thromboplastin Used. Clinical Chemistry. 1999;45:409-412.
[texto integral]
¤ Levi M. Disseminated Intravascular Coagulation: New Diagnostic Criteria and Supportive Treatmente Strategies. 47 th Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis. July 6-7, 2001, Paris, France. Medscape Cardiology, 2001.
¤ Levi M, ten Cate H, van der Poll T, et al. Pathogenesis of Disseminated Intravascular Coagulation in Sepsis. JMA. 1993;270:975-9.
¤ Lopes JA, Andrews RK, Afshar-Kharghan V, et al. Bernard-Soulier Syndrome. Blood 1998;91(12): 4397-4418.
[texto integral]
¤ Mannucci PM, Lombardi R, Bader R, et al. Studies on the Pathophysiology of Acquired von Willebrand Disease in Seven patients with Lymphoproliferative Disorders or Benign Monoclonal Gammopathies. Blood 1984;64:614.
¤ Mannucci PM and Remuzzi G. von Willebrand Factor Cleaving Protease in Patients with and without Thrombotic Microangiopathies (TTP and HUS) in Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders. Hematology 2001:282-305.
[texto integral]
¤ Mohri H, Motomura S, Kanamori H, et al. Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome. Blood. 1998; 91(10):3623-29.
[texto integral]
¤ Martin GS. The Complex Role of Coagulation in the Pathophysiology of Sepsis. 30 th International Educational and Scientific Symposium of the Society of Critical Care Medicine. Day 1 - February 10, 2001
¤ Martin GS. Current Management Strategies for Severe Sepsis and Septic Shock. 67 th Annual Sceintific Assembly of the American College of Chest Physicians. November 4 - 8, 2001, Philadelphia, Pennsylvania.
[texto integral]
¤ Martin GS. Sepsis: An Evolution of Concepts and Definitions. 31 th International Educational and Scientific Symposium of the Society of Critical Care Medicine. January 26 - 30, 2002, San Diego, California. [texto integral]
¤ Mutunga M, Fulton B, Bullock R, et al. Circulating Endothelial Cells in Patients with Septic Shock. Am J Respir Crit Care Med. January 2001;163:195-200.
[texto integral]
¤ Poller L. Progress in standardization in anticoagulant control. Hematol Rev Commun 1987;1:225-41.
¤ Rao AK and Gabbeta J. Congenital Disorders of Platelet Signal Transduction. Arterioscler Thromb Vasc Biol. 2000;20:285-9.
[texto integral]
¤ Salgado DR. Sepse e choque séptico: fisiopatogenia. Artigo do site Medstudents. [texto integral]
¤ Schmaier AH. Disseminated Intravascular Coagulation. eMedicine Journal, November 23 2001, Volume 2, Number 11.
[texto integral]
¤ Sharma S. Septic Shock. eMedicine Journal, April 8 2002, Volume 3, Number 4.
[texto integral]
¤ Triplett DA. Coagulation and Bleeding Disorders: Reviw and Update. Clinical Chemistry 2000; 46(8):1260-69.
[texto integral]
¤ White GC. von Willebran's Disease. Education Program. IX th Congress of the International Society of Haematology. Asian-Pacific Division. Bangkok, Thailand. Oct. 24-28,1999.
[texto integral]
¤ Zhou Q, Sims PJ and Wiedmer T. Expression of Proteins Controlling Transbilayer Movement of Plasma Membrane Phospholipids in the B Lymphocytes From a Patient With Scott Syndrome. Blood. 1998;92(5):1707-12.
[texto integral]
